ORGO
Organogenesis Holdings Inc.Company Information
- Company Name
- Organogenesis Holdings Inc.
- CIK
- CIK0001661181
- Category
- Accelerated filer
- Ticker: Exchange
- ORGO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ORGO
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-09
- Last sale
- 2025-12-16
- Shares purchased (TTM)
- 131,516
- Shares sold (TTM)
- 406,577
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 64,481,614
- Shares outstanding
- 128,674,548
- Ownership
- 50.11%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -27.80%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 46 | 91 | 94 | 64 | 73 | 110 | 136 | 94 | 90 | 89 | 104 | 98 | ||||||
| Restricted Cash Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | ||||||
| Accounts Receivable Net Current | 101 | 117 | 217 | 169 | 120 | 103 | 110 | 101 | 106 | 96 | 82 | 89 | ||||||
| Inventory Net | 29 | 28 | 30 | 40 | 33 | 29 | 26 | 27 | 27 | 28 | 28 | 28 | ||||||
| Assets Held In Trust Current | 4 | 2 | 2 | 4 | 5 | 7 | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 20 | 29 | 18 | 23 | 28 | 18 | 14 | 15 | 11 | 14 | 10 | 10 | ||||||
| Assets Current | 200 | 269 | 362 | 300 | 260 | 268 | 286 | 239 | 234 | 227 | 225 | 226 | ||||||
| Property Plant And Equipment Net | 102 | 104 | 104 | 78 | 76 | 76 | 89 | 90 | 90 | 114 | 116 | 118 | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 3 | 9 | 10 | 11 | 12 | 12 | 13 | 14 | 15 | 16 | 17 | ||||||
| Goodwill | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | ||||||
| Operating Lease Right Of Use Asset | 50 | 54 | 56 | 33 | 35 | 37 | 37 | 35 | 37 | 39 | 40 | 42 | ||||||
| Deferred Income Tax Assets Net | 0 | 45 | 30 | 46 | 42 | 41 | 39 | 36 | 34 | 28 | 28 | 30 | ||||||
| Other Assets Noncurrent | 23 | 16 | 9 | 14 | 9 | 6 | 5 | 5 | 6 | 7 | 6 | 1 | ||||||
| Assets | 406 | 520 | 599 | 510 | 461 | 467 | 498 | 446 | 443 | 458 | 460 | 463 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Secured Debt Current | - | - | - | - | - | - | - | 6 | 6 | 5 | 5 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Finance Lease Liability Current | 1 | 1 | 9 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | 4 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 13 | ||||||
| Accounts Payable Current | 29 | 29 | 32 | 40 | 30 | 25 | 29 | 24 | 29 | 23 | 31 | 27 | ||||||
| Liabilities Current | 57 | 76 | 100 | 90 | 66 | 65 | 77 | 77 | 86 | 83 | 81 | 81 | ||||||
| Secured Long Term Debt | - | - | - | - | - | - | - | 56 | 58 | 59 | 61 | 62 | ||||||
| Finance Lease Liability Noncurrent | 11 | 12 | 13 | 2 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Noncurrent | 21 | 22 | 22 | 24 | 25 | 26 | 25 | 23 | 23 | 24 | 25 | 39 | ||||||
| Other Liabilities Noncurrent | 4 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 118 | 139 | 165 | 124 | 100 | 99 | 113 | 168 | 180 | 180 | 181 | 186 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | 0 | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 140 | 137 | 134 | 131 | 128 | 125 | 122 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 301 | 301 | 303 | 302 | 302 | 302 | 303 | 326 | 324 | 321 | 320 | 317 | ||||||
| Retained Earnings Accumulated Deficit | -153 | -56 | -3 | -47 | -68 | -59 | -40 | -48 | -60 | -43 | -41 | -40 | ||||||
| Stockholders Equity | 148 | 245 | 300 | 255 | 233 | 243 | 263 | 279 | 264 | 278 | 279 | 277 | ||||||
| Liabilities And Stockholders Equity | 406 | 520 | 599 | 510 | 461 | 467 | 498 | 446 | 443 | 458 | 460 | 463 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | 16 | - | - | - | 10 | - | - | - | 7 | - | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | ||||||
| Temporary Equity Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Liquidation Preference | 148 | 145 | 142 | 139 | 137 | 134 | 131 | - | - | - | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | - | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | ||||||
| Common Stock Shares Issued | 129 | 129 | 128 | 128 | 128 | 128 | 126 | 133 | 133 | 133 | 132 | 132 | ||||||
| Shares Outstanding | 129 | 129 | 127 | 127 | 127 | 127 | 126 | 133 | 133 | 133 | 131 | 131 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOrganogenesis Holdings Inc. (ORGO) — SEC Financial Statements & Analysis
Organogenesis Holdings Inc. (ORGO) is a pharmaceutical preparations company, incorporated in DE. Organogenesis Holdings Inc. trades on Nasdaq as: ORGO. Organogenesis Holdings Inc. (ORGO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Organogenesis Holdings Inc. carries a market cap of $312.68M, a P/E ratio of -3.08x, a P/B ratio of 2.11x, a P/S ratio of 0.68x, an enterprise value of $277.51M, and an EV/EBITDA multiple of -13.92x. On profitability, it posts a gross margin of 75.85%, an operating margin of -7.84%, a net margin of -22.17%, a Return on Equity (ROE) of -53.17%, a Return on Assets (ROA) of -23.38%, and a Return on Invested Capital (ROIC) of -24.59%. Per share, it reports EPS of $-0.79, diluted EPS of $-0.79, free cash flow per share of $0.16, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 6.50% year-over-year, net income growth of 818.65% year-over-year, and EPS growth of 805.65% year-over-year. On the balance sheet, it maintains a current ratio of 3.52x, a quick ratio of 2.66x, working capital of $143.34M, a debt-to-equity ratio of 0.80x, a debt ratio of 0.29, an interest coverage ratio of -30.68x, free cash flow of $20.84M (TTM), and net debt of $-35.16M. Figures sourced from SEC EDGAR.
- Market Cap
- $312.68M
- P/E TTM
- -3.08x
- EPS TTM
- $-0.79
- P/B TTM
- 2.11x
- ROE TTM
- -53.17%
- ROA TTM
- -23.38%
- Debt To Equity
- 0.80x
- Free Cash Flow TTM
- $20.84M
- Net Revenue TTM Growth 1Y
- 6.50%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Organogenesis Holdings Inc. in?
Organogenesis Holdings Inc. (ORGO) operates in the Pharmaceutical Preparations industry.
What exchange does ORGO trade on?
Organogenesis Holdings Inc. (ORGO) trades on the Nasdaq.
Where is Organogenesis Holdings Inc. incorporated?
Organogenesis Holdings Inc. is incorporated in DE.
When was Organogenesis Holdings Inc. (ORGO)'s most recent SEC filing?
Organogenesis Holdings Inc. (ORGO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is ORGO's market cap?
Organogenesis Holdings Inc. (ORGO) has a market capitalization of $312.68M as of 2026-06-30.
What is ORGO's EPS (earnings per share)?
Organogenesis Holdings Inc. (ORGO)'s trailing twelve month EPS is $-0.79 as of 2026-06-30.
What is ORGO's ROE (return on equity)?
Organogenesis Holdings Inc. (ORGO)'s trailing twelve month Return on Equity (ROE) is -53.17% as of 2026-06-30.
What is ORGO's ROA (return on assets)?
Organogenesis Holdings Inc. (ORGO)'s trailing twelve month Return on Assets (ROA) is -23.38% as of 2026-06-30.
What is ORGO's ROIC (return on invested capital)?
Organogenesis Holdings Inc. (ORGO)'s trailing twelve month Return on Invested Capital (ROIC) is -24.59% as of 2026-06-30.
What is ORGO's EV/EBITDA?
Organogenesis Holdings Inc. (ORGO)'s trailing twelve month EV/EBITDA is -13.92x as of 2026-06-30.